Unraveling Immune Dysregulation in ZNFX1 Deficiency: From Interferonopathies to Macrophage Activation Syndrome
Journal of Clinical Immunology · Published 2026-08-06 · DOI 10.1007/s10875-026-02056-4
Free full text
Authors (15)
Sara G. Hamad, Melanie Makhlouf, Nourhen Agrebi, Ahmad Kaddourah, Mutasim Abu-Hasan, Buthaina Al-Adba, Ameera Sadoun, Satanay Z. Hubrack, Waleed Aamer, Mayra L. Ruiz Tejada Segura, Antonio Scialdone, Khaled Machaca, Luis R. Saraiva, Sharon Bout-Tabaku, Bernice Lo
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Hamad, S., Makhlouf, M., Agrebi, N., et al. (2026). Unraveling Immune Dysregulation in ZNFX1 Deficiency: From Interferonopathies to Macrophage Activation Syndrome. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-026-02056-4
Related articles
- Genetic Diagnosis and Identification of a Novel De Novo RELA Variant in Familial Behçet-like Autoinflammatory Syndrome Type 3: A Case Report · Journal of Clinical Immunology · 2026 · Same journal
- Biallelic MCM10 Deficiency Presenting with Natural Killer Cell Deficiency, Poikiloderma and EBV-Associated Malignancy · Journal of Clinical Immunology · 2026 · Same journal
- Hypoproteinemia and Hypogammaglobulinemia Due to a Homozygous FCGRT Mutation · Journal of Clinical Immunology · 2026 · Same journal
- Disseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report · Journal of Clinical Immunology · 2026 · Same journal
- Humoral Immune Abnormalities in Transient Childhood Neutropenia: Insights From a 10-year Cohort Study in a Tertiary Center · Journal of Clinical Immunology · 2026 · Same journal
- Phenotypic Heterogeneity in CD40 Ligand Deficiency: Long-term Follow-up of a Patient with the c.156G > A Splice Variant · Journal of Clinical Immunology · 2026 · Same journal
- First-in-Human, Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of TNX-1500, an Fc-Modified anti-CD154 Monoclonal Antibody, Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses in Healthy Adults · Journal of Clinical Immunology · 2026 · Same journal
- Antigen Microarray Reveals Broad and Subclinical Autoimmunity in Patients with Inborn Errors of Immunity · Journal of Clinical Immunology · 2026 · Same journal
- Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome · Journal of Clinical Immunology · 2026 · Same journal
- Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of Immunity · Journal of Clinical Immunology · 2026 · Same journal